Japanese Encephalitis Vaccine Completed Phase 4 Trials for Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)

Also known as: Japanese Encephalitis Vaccines

IndicationStatusPhase
DBCOND0058552 (Japanese Encephalitis Vaccine)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01656200A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2Basic Science